Our review of retapamulin (DTB 2008; 46: 76–9) described a trial that compared retapamulin and oral cefalexin in people with infected dermatoses.1 In doing so, we incorrectly stated that the study was underpowered with regards to the number of patients included in its per-protocol analysis. This error does not affect our article's Conclusion.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.